Literature DB >> 26347111

Hemorrhagic cystitis in a patient without a past history of radiation therapy who was treated with cabazitaxel for CRPC.

T Kosaka1, M Oya2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26347111     DOI: 10.1093/annonc/mdv362

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxel.

Authors:  Takeo Kosaka; Hiroshi Hongo; Ryuichi Mizuno; Mototsugu Oya
Journal:  Mol Clin Oncol       Date:  2018-09-19

2.  Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin.

Authors:  Mehmet Asim Bilen; Diana H Cauley; Bradley J Atkinson; Hsiang-Chun Chen; Diana H Kaya; Xuemei Wang; Raghu Vikram; Shi-Ming Tu; Paul G Corn; Jeri Kim
Journal:  Clin Genitourin Cancer       Date:  2016-12-13       Impact factor: 2.872

3.  Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxel.

Authors:  Takeo Kosaka; Toshiaki Shinojima; Shinya Morita; Mototsugu Oya
Journal:  Cancer Sci       Date:  2018-04-10       Impact factor: 6.716

4.  Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations.

Authors:  Ken Kamisawa; Takeo Kosaka; Kohei Nakamura; Yota Yasumizu; Hiroshi Hongo; Toshikazu Takeda; Kazuhiro Matsumoto; Hiroshi Nishihara; Mototsugu Oya
Journal:  Cancer Sci       Date:  2022-07-18       Impact factor: 6.518

5.  No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer.

Authors:  Takeo Kosaka; Hiroshi Hongo; Keitaro Watanabe; Ryuichi Mizuno; Eiji Kikuchi; Mototsugu Oya
Journal:  Cancer Chemother Pharmacol       Date:  2018-10-03       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.